Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Antireumático")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4176

  • Page / 168
Export

Selection :

  • and

Gold sodium thiomalate activates latent human leukocyte collagenaseLINDY, S; SORSA, T; SUOMALAINEN, K et al.FEBS letters. 1986, Vol 208, Num 1, pp 23-25, issn 0014-5793Article

The clinical evaluation of anti-rheumatic drugsCATALANO, M. A.Collection sécurité. 1986, Vol 19, Num 3-4, pp 244-245, issn 0538-4818Article

Prior Authorization for Biologic Disease-Modifying Antirheumatic Drugs : A Description of US Medicaid ProgramsFISCHER, Michael A; POLINSKI, Jennifer M; SERVI, Amber D et al.Arthritis care and research. 2008, Vol 59, Num 11, pp 1611-1617, issn 0893-7524, 7 p.Article

Pharmacologie générale d'un nouvel antirhumatismal, le lobenzaritKAKIMOTO, M; WATANABE, M; HATA, S et al.Yakuri to chiryo. 1987, Vol 15, Num 12, pp 227-253, issn 0386-3603Article

Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectivenessBIGGEE, B. A; BLINN, C. M; MCALINDON, T. E et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 2, pp 222-226, issn 0003-4967, 5 p.Article

PfCRT and the trans-vacuolar proton electrochemical gradient : regulating the access of chloroquine to ferriprotoporphyrin IXBRAY, Patrick G; MUNGTHIN, Mathirut; FIDOCK, David A et al.Molecular microbiology (Print). 2006, Vol 62, Num 1, pp 238-251, issn 0950-382X, 14 p.Article

Les médications antirhumatismales : Une histoire édifiante = Drugs used in rheumatic diseases : an instructive storyASCH, L.La Semaine des hôpitaux de Paris. 1996, Vol 72, Num 19-20, pp 622-624, issn 0037-1777Conference Paper

Proceedings/Ridaura (auranofin): 1986, a Smith Kline and French international symposium, Amsterdam 21 June 1986DAVIS, T. G.Scandinavian journal of rheumatology. Supplement. 1986, issn 0301-3847, 95 p., suppl. 63Conference Proceedings

DRESS et hydroxychloroquine = Hydroxychloroquine and DRESSSCHMUTZ, J.-L; BARBAUD, A; TRECHOT, P et al.Annales de dermatologie et de vénéréologie. 2008, Vol 135, Num 12, pp 903-903, issn 0151-9638, 1 p.Article

Methylsulphasalazine in rheumatoid arthritisASTBURY, C; HILL, J; LOWE, J. R et al.British journal of rheumatology. 1990, Vol 29, Num 6, pp 465-467, issn 0263-7103Article

Gold-induced pneumonitisSLINGERLAND, R; HOOGSTEDEN, H. C; ADRIAANSEN, H. J et al.Respiration (Basel). 1987, Vol 52, Num 3, pp 232-236, issn 0025-7931Article

Les nouveaux anti-TNFαWENDLING, D.La Lettre du rhumatologue. 2009, Num 356, pp 14-15, issn 0761-5027, 2 p., SUPArticle

Glucosamine Found as a Substituent of Both Phosphate Groups in Bordetella Lipid A Backbones : Role of a BvgAS-Activated ArnT OrthologMARR, Nico; TIRSOAGA, Alina; BLANOT, Didier et al.Journal of bacteriology. 2008, Vol 190, Num 12, pp 4281-4290, issn 0021-9193, 10 p.Article

What's new with hyaluronic acid fillersGOLD, Michael H.Journal of drugs in dermatology. 2007, Vol 6, Num 10, pp 1050-1053, issn 1545-9616, 4 p.Article

JUVÉDERM : A HYALURONIC ACID DERMAL FILLERMONHEIT, Gary D; PRATHER, Chad L.Journal of drugs in dermatology. 2007, Vol 6, Num 11, pp 1091-1095, issn 1545-9616, 5 p.Article

Depolymerization of β-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilmsITOH, Yoshikane; XIN WANG; HINNEBUSCH, B. Joseph et al.Journal of bacteriology. 2005, Vol 187, Num 1, pp 382-387, issn 0021-9193, 6 p.Article

Collagène, acides hyaluronique et polylaclique : peut-on encore améliorer les résultatsMICHEELS, P.Journal de médecine esthétique et de chirurgie dermatologique. 2004, Vol 31, Num 124, pp 223-227, issn 0249-6380, 5 p.Article

Management of Coccidioidomycosis in Patients Receiving Biologic Response Modifiers or Disease-Modifying Antirheumatic DrugsTAROUMIAN, Sara; KNOWLES, Susan L; LISSE, Jeffrey R et al.Arthritis care & research (2010 : Print). 2012, Vol 64, Num 12, pp 1903-1909, issn 2151-464X, 7 p.Article

Adherence to Disease-Modifying Antirheumatic Drugs and the Effects of Exposure Misclassification on the Risk of Hospital AdmissionGRIJALVA, Carlos G; KALTENBACH, Lisa; ARBOGAST, Patrick G et al.Arthritis care and research. 2010, Vol 62, Num 5, pp 730-734, issn 0893-7524, 5 p.Article

Acide hyaluronique = Hyaluronic acidHUMBERT, P.Annales de dermatologie et de vénéréologie. 2010, Vol 137, issn 0151-9638, 45 p., SUP1Serial Issue

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologistsGOSSEC, L; BIJLSMA, J. W. J; MIELANTS, H et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 2, pp 388-389, issn 0003-4967, 2 p.Article

Les stratégies d'utilisation du méthotrexateWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 60, pp 2-4, issn 1771-0081, 3 p., CAH2Article

The cycling of combination antirheumatic drug therapy in rheumatoid arthritisSCHWARZER, A. C; ARNOLD, M. H; KELLY, D et al.British journal of rheumatology. 1990, Vol 29, Num 6, pp 445-450, issn 0263-7103Article

The use of antirheumatic medication during pregnancy and in the puerperiumBROOKS, P. M; NEEDS, C. J.Rheumatic disease clinics of North America. 1989, Vol 15, Num 4, pp 789-806, 18 p.Article

Dermatitis exfoliativa por sales de oro = Erythrodermie induite par chrysothérapie = Exfoliative dermatitis to chrysotherapyGIMENEZ GARCIA, R; ALTUZARRA, L. M.Actas dermo-sifiliográficas (Ed. impresa). 1987, Vol 78, Num 7-8, pp 525-527, issn 0001-7310Article

  • Page / 168